Array Biopharma INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersBoulder, CO
US patents328
SAM.gov UEIU9W8WHJ4MNC4
CAGE code7GFS2
Incorporated inCO
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
328 US patents granted 2001–2025, 50 of them in the five years to SEP 2025.
Pharmaceuticals 236Organic fine chemistry 89Chemical engineering 2
- Pharmaceutical compositionUS 12,364,684 · granted JUL 22, 2025
- Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinasesUS 12,351,571 · granted JUL 8, 2025
- Pharmaceutical compositionUS 12,318,367 · granted JUN 3, 2025
- Pharmaceutical compositionUS 12,220,403 · granted FEB 11, 2025
- Protein tyrosine phosphatase inhibitorsUS 12,187,721 · granted JAN 7, 2025
Newest 5 shown · Granted to Array BioPharma, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Array Biopharma INC | Boulder | CO | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.